Cargando…
A Clinical Viewpoint on the Use of Targeted Therapy in Advanced Gastric Cancer
SIMPLE SUMMARY: Outcomes for patients with advanced gastric cancer continue to be unsatisfactory despite the inclusion of new targeted therapies in the treatment options. The effectiveness of targeted therapies is limited for a particular subset of the population. This is related to the fact that sp...
Autores principales: | Skórzewska, Magdalena, Gęca, Katarzyna, Polkowski, Wojciech P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670421/ https://www.ncbi.nlm.nih.gov/pubmed/38001751 http://dx.doi.org/10.3390/cancers15225490 |
Ejemplares similares
-
FGFR Inhibitors in Cholangiocarcinoma—A Novel Yet Primary Approach: Where Do We Stand Now and Where to Head Next in Targeting This Axis?
por: Chmiel, Paulina, et al.
Publicado: (2022) -
Prognostic value of molecular cytology by one-step nucleic acid amplification (OSNA) assay of peritoneal washings in advanced gastric cancer patients
por: Gęca, Katarzyna, et al.
Publicado: (2022) -
The Role of the Lymph Node Ratio in Advanced Gastric Cancer After Neoadjuvant Chemotherapy
por: Rawicz-Pruszyński, Karol, et al.
Publicado: (2019) -
Author Correction: Prognostic value of molecular cytology by one‑step nucleic acid amplifcation (OSNA) assay of peritoneal washings in advanced gastric cancer patients
por: Gęca, Katarzyna, et al.
Publicado: (2023) -
Molecular Cytology by One-Step Nucleic Acid Amplification (OSNA) Assay of Peritoneal Washings during D2 Gastrectomy in Advanced Gastric Cancer Patients: Preliminary Results
por: Gęca, Katarzyna, et al.
Publicado: (2021)